HSBC Holdings Portfolio holdings
HSBC Holdings plc, founded in 1865 as the Hongkong and Shanghai Banking Corporation by Sir Thomas Sutherland to finance trade in East Asia, is a British multinational bank headquartered in London, managing trillions in assets as one of the world’s largest banking and financial services organizations. Operating in over 60 countries with a strong emphasis on Asia—where it generates much of its revenue—HSBC offers retail banking, wealth management, commercial banking, and global markets services to more than 40 million customers, supported by around 214,000 employees as of late 2024. Known for its international network and resilience through crises like the 1997 Asian financial downturn, HSBC has pivoted under Group CEO Noel Quinn (since 2020) to accelerate digital transformation and sustainability goals, targeting net-zero emissions by 2050. Despite challenges like geopolitical tensions and regulatory pressures, HSBC remains a cornerstone of global finance, leveraging its heritage as a trade financier into a modern, Asia-centric banking powerhouse.
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$911M |
| 2 |
Galicia Financial Group
GGAL
|
+$714M |
| 3 |
TSMC
TSM
|
+$364M |
| 4 |
Lam Research
LRCX
|
+$285M |
| 5 |
Tesla
TSLA
|
+$222M |
Top Sells
| 1 |
Flutter Entertainment
FLUT
|
+$1.38B |
| 2 |
Microsoft
MSFT
|
+$895M |
| 3 |
Apple
AAPL
|
+$735M |
| 4 |
Amazon
AMZN
|
+$567M |
| 5 |
Meta Platforms (Facebook)
META
|
+$435M |
Sector Composition
| 1 | Technology | 33.91% |
| 2 | Financials | 12.82% |
| 3 | Consumer Discretionary | 11.38% |
| 4 | Healthcare | 8.99% |
| 5 | Communication Services | 8.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
RVNC
2576
DELISTED
Revance Therapeutics, Inc.
RVNC
| $36.8K | ﹤0.01% |
12,111
-1,158,327
| -99% | -$3.52M |
|
|
SLRN
2577
DELISTED
ACELYRIN
SLRN
| $36.3K | ﹤0.01% |
+11,663
| New | +$36.3K |
|
|
KRON
2578
DELISTED
Kronos Bio
KRON
| $36.3K | ﹤0.01% |
38,368
| – | – |
|
2579
Fossil Group
FOSL
$161M
| $35.9K | ﹤0.01% |
20,646
-80
| -0.4% | -$139 |
|
2580
Taysha Gene Therapies
TSHA
$903M
| $35.6K | ﹤0.01% |
20,391
+8,076
| +66% | +$14.1K |
|
2581
Wheels Up
UP
$1.53B
| $35.5K | ﹤0.01% |
21,775
+10,740
| +97% | +$17.5K |
|
2582
Quantum-Si Incorporated
QSI
$223M
| $34.5K | ﹤0.01% |
11,742
-656
| -5% | -$1.93K |
|
2583
Olaplex Holdings
OLPX
$967M
| $34.5K | ﹤0.01% |
+19,879
| New | +$34.5K |
|
2584
Solid Power
SLDP
$669M
| $34.3K | ﹤0.01% |
18,018
-1,398
| -7% | -$2.66K |
|
|
ALLK
2585
DELISTED
Allakos
ALLK
| $34.2K | ﹤0.01% |
28,243
| – | – |
|
2586
Microvision
MVIS
$337M
| $34.1K | ﹤0.01% |
24,564
+6,505
| +36% | +$9.04K |
|
2587
Cassava Sciences
SAVA
$104M
| $33.9K | ﹤0.01% |
+14,762
| New | +$33.9K |
|
|
TE
2588
T1 Energy Inc.
TE
$298M
| $33.7K | ﹤0.01% |
13,043
-9,572
| -42% | -$24.7K |
|
2589
The ONE Group
STKS
$83M
| $32.8K | ﹤0.01% |
11,106
-3,184
| -22% | -$9.39K |
|
|
SYT
2590
DELISTED
SYLA Technologies
SYT
| $32.5K | ﹤0.01% |
+17,475
| New | +$32.5K |
|
2591
Compass Therapeutics
CMPX
$597M
| $32.1K | ﹤0.01% |
21,529
-931
| -4% | -$1.39K |
|
2592
SES AI
SES
$406M
| $30.8K | ﹤0.01% |
15,327
-1,112
| -7% | -$2.24K |
|
|
CLYM
2593
Climb Bio, Inc. Common Stock
CLYM
$162M
| $30K | ﹤0.01% |
+16,748
| New | +$30K |
|
2594
Angi Inc
ANGI
$809M
| $29.7K | ﹤0.01% |
+1,792
| New | +$29.7K |
|
2595
Lightwave Logic
LWLG
$405M
| $28.9K | ﹤0.01% |
13,966
-412
| -3% | -$853 |
|
2596
Ocugen
OCGN
$325M
| $26.8K | ﹤0.01% |
33,296
+2,663
| +9% | +$2.14K |
|
2597
FibroGen
FGEN
$46.5M
| $26.8K | ﹤0.01% |
2,088
| – | – |
|
2598
Karyopharm Therapeutics
KPTI
$54.1M
| $26.5K | ﹤0.01% |
2,687
| – | – |
|
2599
ALX Oncology
ALXO
$57.3M
| $25.6K | ﹤0.01% |
16,154
+2,235
| +16% | +$3.54K |
|
2600
Prelude Therapeutics
PRLD
$66.2M
| $25.6K | ﹤0.01% |
20,640
-132
| -0.6% | -$164 |
|